Loading...
HomeMy WebLinkAbout121322 Year in review_ The most important and interesting stories of 2022________________________________ ALERT: BE CAUTIOUS This email originated outside the organization. Do not open attachments or click on links if you are not expecting them. ________________________________ Year in review | Finding a new TB vaccine | What are secondary cancers ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ View as Web page <https://secure.fredhutch.org/site/R?i=nZ6GOEXQW1E95LuNHlbSDcKpLLy7GUOVbXGkt5i5O9LsURSLFIiU8w> <https://secure.fredhutch.org/site/R?i=whTM7Xxb1m1pxJ7ZMMhz2UIzysoVtxeE9ST50RMQemHt_c74tgnetA> <https://secure.fredhutch.org/images/content/pagebuilder/fhcc-eml-hdr-shadow.png> <https://secure.fredhutch.org/site/R?i=3pyCYKspWziwEU5R8v4Iun6KDHugNbVBDfP7ixYqrRQBr0tC9YVyxA> December 13, 2022 ⋅ A monthly digest of the latest from Fred Hutch Year in Review 2022 <https://secure.fredhutch.org/site/R?i=_w-lBG-wn5yzT7VzUm52H3pz_uow0-mvJs9jsQXZUGEJ500gl00I0Q> This year brought significant changes for us, most evidenced by a new name – Fred Hutchinson Cancer Center – to reflect a new organization that unites comprehensive care and advanced research to provide the latest cancer treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases. As 2022 winds down, we review <https://secure.fredhutch.org/site/R?i=4BXQ22zjngJp9cG4C1fIv-2hsMysieIp1caJQgZJSUqxG-ZGtoTdKA> the important news, remarkable stories, significant research and compelling images from throughout the year. ________________________________ Year in Pictures: 2022 <https://secure.fredhutch.org/site/R?i=xcn3Uj6jecmyU5Fb4AoFcIHR3bsKkfYDiRA5k0UaATU-4ydj2yvyUQ> <https://secure.fredhutch.org/site/R?i=LjwA06oI9UV9si0En6O9SGjlMC3fx7Vpc1KzV_Mf1IXSt2E8lyUr1A> The Nabet Lab aims to develop new therapeutic strategies that capitalize on the cell's own trash-disposal machinery to eliminate cancer-causing proteins. Nabet Lab graduate student Jennifer Crainic is working to create light-controlled technologies that disable and remove cancer drug targets with limited toxicity and side effects. See more in the Year in Pictures <https://secure.fredhu tch.org/site/R?i=ncZWStqM1IrvHUAeAvD9c73eadX9VjTp4d-xqbd_AyaoJ3U5zp4hqQ> . ________________________________ The Latest Tracking prostate cancer dynamics <https://secure.fredhutch.org/site/R?i=iZ4oHD6Ae3q8ZdvDtARntaVvIsrz_X8wjGiGRbUbII74eT3I_5VMYg> New research from the Hsieh Lab using single-cell sequencing gives scientists an unprecedentedly detailed look at individual cells as prostate cancer develops and turns treatment-resistant in models of the disease. Could a 100-year-old TB vaccine help scientists find a better one? <https://secure.fredhutch.org/site/R?i=z9DTALqf8gPkasOoqyYyvYcyyfN7LfxllkU1y3FsgjH-Lhb52wOrHw> Chances are you have never heard of BCG, a 100-year-old vaccine that is still given in the developing world to protect millions of children from tuberculosis. Today, vaccine scientist Jim Kublin, is applying 21st century laboratory tools to see if BCG can help future clinical trials to assess new drugs and better vaccines to stop TB. On World AIDS Day, a broad view of continuing work <https://secure.fredhutch.org/site/R?i=yXfWFKH86-atiX9SyoligfC1dJUu6NVK_0bRuf8SarPXEr8btusiUQ> From the earliest days of HIV/AIDS, Fred Hutch virologists, immunologists and epidemiologists have played leading roles in the efforts to understand the virus, test treatments for it, and find ways to prevent it. While worldwide efforts to develop a vaccine for HIV/AIDS have yet to produce one, the work continues. What Are Secondary Cancers? <https://secure.fredhutch.org/site/R?i=S4x-NZdbWHl6bveKLbpd3vtDsssDIrw5y8TLeFPO4FyoqRg4ptELyw> In this blog post, hear from Stephanie Schaub, MD, regarding secondary cancers, gather resources for facing the holidays while dealing with cancer, and get to know Neil Panjwani, MD. A man with a plan and a purpose to live <https://secure.fredhutch.org/site/R?i=DbdQx9aZwCpFrRGZL9w0dyXUH1z8ULn8BVqNGnb837-oHFOvzaQkuw> A profile of Jim Weber, a Fred Hutch patient and supporter who chronicled his professional and cancer journeys in a new memoir, Running With Purpose. Two Young Patients Connect at Fred Hutch <https://secure.fredhutch.org/site/R?i=tr1bctcItF-sde7kodzqFAXqa4wdED46jvLFe-sU9KWFaKC52e91yw> Six-year-old Connor and eight-year-old Brayden are two unlikely friends with some striking similarities in their lives. The two young boys live in different states but are connected by their experience with cancer. ________________________________ Double Your Lifesaving Impact! Give by December 31 and your gift will be matched. <https://secure.fredhutch.org/site/R?i=4hEheQZBA7rhgNUrb1UlZ1INZQ04XvXFTbFUQAMNym9BS2RwXGg7Nw> ________________________________ Share this newsletter with family or friends <https://secure.fredhutch.org/site/R?i=iiIfSUFT05fozlVSMB-rrc6CRmRpUuf4QUv4MgTjt38cTH812ef4UA> <https://secure.fredhutch.org/site/R?i=Qg6kwu1hXA8IhFQ4LTvF2P9AkEOJSwYvCvHbwv2G-jUNXkLd4IMLlQ> 1100 Fairview Ave. N., Seattle, WA 98109 communications@fredhutch.org <mailto:communications@fredhutch.org> 206.667.5000 <https://secure.fredhutch.org/site/R?i=40GjO4x8mMa19zihEX28MDEjx9Ktlb5syymFprzJ0AfwXLQARfECJA> <https://secure.fredhutch.org/site/R?i=LqTYr3gCQj37SjswKgL5Mx-u_GweML0ytJFNkDpYiTkMj_CTH8cVbg> <https://secure.fredhutch.org/site/R?i=9v2DS4D-4B-x8zKrJWtERX-z4kXMqgWKBZskrJLVR2IVrq5Qn1s1KQ> <https://secure.fredhutch.org/site/R?i=iS3FbTp8p5vXl8a31gEsMEK_ZCyETc9ogkMMb6_N-1EeonW88LH83A> ________________________________ Fred Hutchinson Cancer Center is a 501(c)(3) nonprofit organization. You can adjust your email preferences <http://engage.fredhutch.org/site/CO?i=pzoRDl9hO0g9QE_wLRKS1Sv-sDL0WlLrNLm-Ee6Vg5ni4vOtI13DXCV7Z2wI88z1&cid=1021> at any time or contact us at optout@fredhutch.org <mailto:optout@fredhutch.org> to be removed from both mail and email lists. For information about our privacy practices, see our Privacy Policy <https://secure.fredhutch.org/site/R?i=5LwUuv6VgZaxViFEv-7iN3PMS3Iln3bqJmulitdPwvh-5uAGcYreDw> . © 2022 Fred Hutchinson Cancer Center. All rights reserved. <http://engage.fredhutch.org/site/PixelServer?j=BtfTErPforxg42NSWvcIul-8OO4yCwZBgOt_Hf27VER2MeEKm5oRFA> id 15.0.1497.42 via Mailbox Transport; Tue, 13 Dec 2022 16:00:23 -0800 Received: from mail2013ca1.internal.county.domain (10.10.15.120) by mail2013mbx1.internal.county.domain (10.10.15.121) with Microsoft SMTP Server (TLS) id 15.0.1497.42; Tue, 13 Dec 2022 16:00:22 -0800 Received: from MAIL2.co.jefferson.wa.us (10.10.14.240) by mail2013ca1.internal.county.domain (10.10.15.120) with Microsoft SMTP Server id 15.0.1497.42 via Frontend Transport; Tue, 13 Dec 2022 16:00:26 -0800 X-ASG-Debug-ID: 1670976050-1209181534704e0001-xG2QsA Received: from outbound-ip107a.ess.barracuda.com (outbound-ip107a.ess.barracuda.com [209.222.82.249]) by MAIL2.co.jefferson.wa.us with ESMTP id uRnz4gmpbYtghoAu for <jeffbocc@co.jefferson.wa.us>; Tue, 13 Dec 2022 16:00:51 -0800 (PST) X-Barracuda-Envelope-From: email_feedback_handler@bbcsreturn.convio.net Received: from mta-QQQW.cluster2.blackbaud.net (mta-QQQW.cluster2.blackbaud.net [216.235.195.13]) by mx-inbound-ea13-218.us-east-2a.ess.aws.cudaops.com (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SH A384 bits=256 verify=NO); Wed, 14 Dec 2022 00:00:36 +0000 Received: from blackbaud.com ([10.64.116.32]) by mta-QQQW.cluster2.blackbaud.net (-); Tue, 13 Dec 2022 18:00:35 -0600 X-Barracuda-Effective-Source-IP: mta-QQQW.cluster2.blackbaud.net[216.235.195.13] X-Barracuda-Apparent-Source-IP: 216.235.195.13 X-VirtualServer: ATX-MTA03-216-13, mta-QQQW.cluster2.blackbaud.net, 10.64.117.54 X-SMHeaderMap: mid="X-MailingID" X-Destination-ID: jeffbocc@co.jefferson.wa.us X-SMFBL: amVmZmJvY2NAY28uamVmZmVyc29uLndhLnVz X-VirtualServerGroup: ATX-MTA03-216-13 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=mta-bbcspool.convio.net; s=selector1; t=1670976035; i=@mta-bbcspool.convio.net; h=FROM:Subject:TO:X-MailingID: Reply-To:Message-ID:List-Unsubscribe:x-campaignID:X-Gateway: Organization:Date:MIME-Version:Content-Type; bh=7g5EFSs6ZzpmGdAU 2CxUCYdTuudF7+lKSPD9PHbTVU8=; b=VejUiX4iltomrcJZ4/3Wm49J5vTt/5VW qx9+WyBGAt0W8H+Zk5cKQHfNsbLUY3ci7eLdrwFUIUpbnZs+ptwZv3PBsLKgSvOO klCiWzJuiU7nq3SIfvNGI+Ud5TPGrQjioovLEoJLxD3sgL06/1WAWNQoHAWNCLO8 T8HOp5wGs7Y= FROM: "Fred Hutch News Service" <communications@fredhutch.org> Subject: Year in review: The most important and interesting stories of 2022 TO: "Phil Johnson" <jeffbocc@co.jefferson.wa.us> X-ASG-Orig-Subj: Year in review: The most important and interesting stories of 2022 X-MailingID: 00000::GP::d9f62a9a-5877-45fa-b5d4-e4f7d3236ed1::4193d96f-df72-4437-9016-19908c7683ba::1340655_50610_1679_E-mail-2::0 Reply-To: Fred Hutch News Service <communications@fredhutch.org> Message-ID: <6a7da0f322dc47ff8ea58d63845c2267@fredhutch.org> List-Unsubscribe: <mailto:mail+_smverp_.00000.GP.d9f62a9a-5877-45fa-b5d4-e4f7d3236ed1.4193d96f-df72-4437-9016-19908c7683ba.1340655_50610_1679_E-mail-2.0._smverp_.jeffbocc=co.jefferson.wa.us@bbcsretur n.blackbaud.net> x-campaignID: Blackbaud_55234152532 X-Gateway: poola2 Organization: Fred Hutchinson Cancer Center Date: Tue, 13 Dec 2022 19:00:35 -0500 MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="NextPart_4860cc16_3cf0_4609_a9fe_4ed7a04a76e8" X-BESS-ID: 1670976036-103546-31124-11042-1 X-BESS-VER: 2019.3_20221213.2104 X-BESS-Apparent-Source-IP: 216.235.195.13 X-BESS-Spam-Status: SCORE=0.00 using global scores of QUARANTINE_LEVEL=N/A KILL_LEVEL=5.0 tests=HTML_MESSAGE Received-SPF: pass (mx-inbound-ea13-218.us-east-2a.ess.aws.cudaops.com: domain of email_feedback_handler@bbcsreturn.convio.net designates 216.235.195.13 as permitted sender) X-BESS-Spam-Report: Code version 3.2, rules version 3.2.2.244784 [from cloudscan14- 181.us-east-2a.ess.aws.cudaops.com] Rule breakdown below pts rule name description ---- ---------------------- -------------------------------- 0.00 HTML_MESSAGE BODY: HTML included in message X-BESS-Spam-Score: 0.00 X-BESS-BRTS-Status: 1 X-Barracuda-Connect: outbound-ip107a.ess.barracuda.com[209.222.82.249] X-Barracuda-Start-Time: 1670976050 X-Barracuda-URL: https://10.10.14.240:443/cgi-mod/mark.cgi X-Barracuda-License: Expired X-Barracuda-BRTS-Status: 1 X-Virus-Scanned: by bsmtpd at co.jefferson.wa.us X-Barracuda-Scan-Msg-Size: 29096 Return-Path: email_feedback_handler@bbcsreturn.convio.net X-MS-Exchange-Organization-Network-Message-Id: 7b9941fe-3f95-473a-1a6c-08dadd66326d X-MS-Exchange-Organization-AuthSource: mail2013ca1.internal.county.domain X-MS-Exchange-Organization-AuthAs: Anonymous